Relzomostat
Relzomostat is a methionine aminopeptidase 2 (MetAP2) inhibitor.Relzomostat may be useful for the research of obesity, type 2 diabetes, and other obesity-associated conditions[1].
Product Specifications
CAS Number
2081078-92-2
UNSPSC
12352005
Target
MetAP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/relzomostat.html
Solubility
10 mM in DMSO
Smiles
C[C@]1([C@H](O1)C/C=C(C)\C)[C@]2([H])[C@]3(CC[C@H]([C@H]2OC)OC(N4CC5(CN(C5)CC(F)F)C4)=O)CO3
Molecular Formula
C24H36F2N2O5
Molecular Weight
470.55
References & Citations
[1]Zahler, Robert; Vath, James E. Preparation of fumagillol spirocyclic and fused bicyclic compounds and their use as MetAP2 inhibitors. WO2017027687A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
132181-APC 100 µL
RAB27B (Ras-related Protein Rab-27B, C25KG) (APC)
Sign In for Pricing
View Details 